aTyr Pharma Announces Positive Data from Phase 1b/2a Clinical Trial Demonstrating Consistent Dose Response for ATYR1923 in Pulmonary Sarcoidosis
Stocks in this Quantisnow insightFinance
Quantisnow market dataNASDAQ
LIFE
Ethos Technologies Inc.
- Market cap
- 30-day
- Sector
- Finance
- Industry
- Specialty Insurers
- Listed since
- 2026
Get push alerts for LIFE
Full LIFE profile on Quantisnow Follow LIFE and get a push notification the moment its next story breaks.